FDA clears MiniMed Go Smart MDI system
23/03/2026
No Comments
The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes. The MiniMed Go
The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes. The MiniMed Go
The same white blood cells that rush to fight infection seem to have a second job: preventing your body from burning too much fat. Researchers
The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in Type 2 diabetes. At the same time, FDA also cleared
Breakthrough T1D UK has received £350,000 gift from the Bukhman Foundation to expand support for people living with Type 1 diabetes. Breakthrough T1D UK, the
Blogger Tim Street, who runs a series of diabetes kit experiments on himself (n=1). In one of his latest blogs on diabettech, he trialled nine
According to a BBC report, there has been an unusual rise in the number of children and teenagers around the world diagnosed with Type 1
Just over half the adults without diabetes who started taking the GLP-1 semaglutide (Wegovy) for weight loss discontinued treatment within a year, with a marked
Foresight Group, a leading regional private equity and infrastructure investment manager, has announced a £3 million investment into MyWay Digital Health Ltd, a digital healthcare
Tirzepatide is associated with a much lower all-cause mortality rate than semaglutide when patients present with Type 2 diabetes, chronic kidney disease (CKD) and heart
Three trials from the QWINT global phase 3 clinical trial programme has found that the once-weekly basal insulin analog efsitora alfa lowers HbA1c as effectively